Read the latest news from the world of Saltigo

2017-07-11

LANXESS featured on Health Briefs TV show airing nationally

Segment featuring Saltidin® (Picaridin) from LANXESS’ Saltigo business unit has started airing in the U.S.

Pittsburgh, PA – July xx, 2017– Specialty chemicals company LANXESS is featured in a segment on effective mosquito and  tick bite protection airing in select markets throughout the United States on the broadcast television show Health Briefs.  As part of a half-hour program, the four-minute LANXESS segment highlights the Saltidin® (Picaridin) insect repellent active ingredient from the Saltigo business unit and the important role it may play in repelling mosquitoes and ticks that may transmit dangerous insect-borne diseases like the Zika virus, West Nile virus, and Lyme disease. 

 

Filming for the segment took place at the LANXESS Corporation headquarters in Pittsburgh, Pa. in November, 2016 and features LANXESS Corporation President and CEO Antonis Papadourakis as well as other LANXESS employees. 

 

Health Briefs is an informational feature program designed to educate the general public on topics, trends and issues related to today’s ever-changing healthcare field.  Topics center on the emerging technologies, progressive treatments, revolutionary people and innovative companies that are all part of the global health industry. 

 

The show’s host, co-executive producer and narrator is Kevin Harrington, who has been welcomed into millions of homes around the world over the years through his programs on both syndicated and paid television.  His launch of the original infomercial in 1985 is still the model used today.  In 2009, Harrington was selected as one of the original ‘Shark Tank’ Sharks on the ABC hit show, and has been featured on over 150 Shark Tank segments as an innovator and pioneer. 

 

Saltidin® (Picaridin) is a highly effective, EPA-registered broad spectrum insect repellent active ingredient that provides long-lasting, effective protection from mosquitoes and ticks.  Known for its skin-friendly properties, it is not oily, greasy or sticky on the skin, and it does not damage plastics or other synthetic materials.  Providing up to 14 hours of protection (depending on formulation), Saltidin (Picaridin) is safe for children when used as directed and can be used with confidence on the whole family.  Currently, there are several major brands of Picaridin-based repellents available in the U.S. and throughout the world, in various concentrations and forms, such as sprays, creams, wipes and sticks.  Picaridin is recommended by the World Health Organization (WHO) for protection against mosquitoes carrying malaria, dengue fever and the Zika and chikungunya viruses. 

 

 

For more information, including repellent brands containing Picaridin, and to view the segment, visit www.picaridin.saltidin.com. 

 

 

LANXESS is a leading specialty chemicals company with sales of EUR 7.7 billion in 2016 and about 19,200 employees in 25 countries. The company is currently represented at 75 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. Through ARLANXEO, the joint venture with Saudi Aramco, LANXESS is also a leading supplier of synthetic rubber. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World) and FTSE4Good.

 

Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.